Clinical trial
Entacapone Augmentation for Schizophrenia
NCT00192855 · Rambam Health Care Campus, Other · Completed
Key facts
| NCT number | NCT00192855 |
|---|---|
| Title | Entacapone Augmentation for Schizophrenia |
| Official title | Entacapone Augmentation for Schizophrenia- A Randomized Controlled Trial |
| Lead sponsor | Rambam Health Care Campus, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Entacapone |
| Enrollment | 52 |
| Start date | Jun 1, 2003 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Aug 25, 2010 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: